

Health Care: Drugs
PROLOR Biotech Inc. (PBTH: AMEX)
$6.49 0.15 | 2.37%
05/17/13 - 04:04 PM ET
358.68K / 273.00K
Vol / Avg. Vol:
6.40 / 6.34
Open / Prev. Close:
6.40 - 6.52
Today's Range:
Portfolios with PBTH
Latest PBTH Headlines from TheStreet
More Financial News for PBTH
Press Releases for PBTH
- SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of PROLOR Biotech, Inc. In Connection With The Sale Of The Company To OPKO Health, Inc. - PR Newswire 04.29.13 | 01:04 pm
- Lifshitz Law Firm Announces Investigation Of Buckeye Technologies Inc., Intuitive Surgical, Inc., MPG Office Trust, Inc., And PROLOR Biotech, Inc. - PR Newswire 04.28.13 | 02:04 pm
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of PROLOR Biotech, Inc. - PR Newswire 04.25.13 | 06:04 pm
- Ryan & Maniskas, LLP Announces Investigation Of PROLOR Biotech, Inc. - PR Newswire 04.25.13 | 10:04 am
- Acquisition Of PROLOR Biotech, Inc. By OPKO Health, Inc. May Not Be In The Best Interests Of PROLOR Shareholders - PR Newswire 04.24.13 | 08:04 pm
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of PROLOR Biotech, Inc. - PBTH - PR Newswire 04.24.13 | 03:04 pm
- Management Buyout Of PROLOR - Law Firm Seeks Higher Price For Shareholders - PR Newswire 04.24.13 | 10:04 am
- PROLOR Biotech To Present At 12th Annual Oppenheimer Israeli Conference - PR Newswire 05.10.11 | 07:05 am
- Spencer Trask Applauds Better Care At Lower Cost For Biotech Products - PR Newswire 06.03.10 | 02:06 pm
- PROLOR Biotech Announces NYSE AMEX Listing - PR Newswire 03.25.10 | 08:03 am
See All Press Releases
Partner Headlines for PBTH